litlas
Log inCreate account

Nancy E. Hynes

Active 1977–2020

85
Papers
23,355
Citations
81
h-index
85
i10-index

Citations

Citations per year for Nancy E. Hynes1978: 5 citations1979: 7 citations1980: 3 citations1981: 19 citations1982: 25 citations1983: 26 citations1984: 34 citations1985: 21 citations1986: 43 citations1987: 35 citations1988: 25 citations1989: 40 citations1990: 50 citations1991: 37 citations1992: 43 citations1993: 38 citations1994: 35 citations1995: 60 citations1996: 89 citations1997: 141 citations1998: 136 citations1999: 195 citations2000: 265 citations2001: 297 citations2002: 264 citations2003: 328 citations2004: 285 citations2005: 276 citations2006: 277 citations2007: 285 citations2008: 312 citations2009: 211 citations2010: 283 citations2011: 243 citations2012: 208 citations2013: 231 citations2014: 185 citations2015: 130 citations2016: 133 citations2017: 128 citations2018: 94 citations2019: 359 citations2020: 329 citations2021: 327 citations2022: 250 citations2023: 154 citations2024: 242 citations2025: 90 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,576 citing papers, 34.7% of this breakdownChina: 559 citing papers, 7.5% of this breakdownGermany: 488 citing papers, 6.6% of this breakdownUnited Kingdom: 450 citing papers, 6.1% of this breakdownItaly: 323 citing papers, 4.4% of this breakdownJapan: 280 citing papers, 3.8% of this breakdownCanada: 249 citing papers, 3.4% of this breakdownFrance: 235 citing papers, 3.2% of this breakdownSwitzerland: 234 citing papers, 3.1% of this breakdownSpain: 178 citing papers, 2.4% of this breakdownAustralia: 164 citing papers, 2.2% of this breakdownIndia: 137 citing papers, 1.8% of this breakdown
0%34.7%Other 20.8%

Institutions

Fields

  • Medicine57.6%
  • Biochemistry, Genetics and Molecular Biology32.7%
  • Immunology and Microbiology2.8%
  • Neuroscience1.6%
  • Nursing1.1%
  • Chemistry1%
  • Other3.2%

Topics

  • HER2/EGFR in Cancer Research11.2%
  • Monoclonal and Polyclonal Antibodies Research7.1%
  • Lung Cancer Treatments and Mutations2.9%
  • Cytokine Signaling Pathways and Interactions2.5%
  • Glycosylation and Glycoproteins Research2.5%
  • Cell Adhesion Molecules Research2.3%
  • Other71.5%

Coauthors

All papers

Open in search
  1. ERBB receptors and cancer: the complexity of targeted inhibitors

    Authors: Nancy E. Hynes, Heidi A. Lane - Nature reviews. Cancer 2005 cited by 3,310

  2. The ErbB signaling network: receptor heterodimerization in development and cancer

    Authors: Monilola A. Olayioye, Richard M. Neve, Heidi A. Lane, Nancy E. Hynes - The EMBO Journal 2000 cited by 2,439

  3. ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

    Authors: Diana Graus-Porta, Roger R. Beerli, J.M. Daly, Nancy E. Hynes - The EMBO Journal 1997 cited by 1,576

  4. ErbB receptors and signaling pathways in cancer

    Authors: Nancy E. Hynes, Gwen MacDonald - Current Opinion in Cell Biology 2009 cited by 980

  5. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

    Authors: Thomas Holbro, Roger R. Beerli, Francisca Maurer, Magdalena Koziczak, Carlos F. Barbas, Nancy E. Hynes - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 960

  6. ErbB Receptors: Directing Key Signaling Networks Throughout Life

    Authors: Thomas Holbro, Nancy E. Hynes - The Annual Review of Pharmacology and Toxicology 2004 cited by 632

  7. Memo Is a Copper-Dependent Redox Protein with an Essential Role in Migration and Metastasis

    Authors: Gwen MacDonald, Ivan Nalvarte, Т. А. Смирнова, Manuela Vecchi, Nicola Aceto, Arno Doelemeyer, Anna Frei, Susanne Lienhard, Jeffrey Wyckoff, Daniel Heß, Jan Seebacher, J.J. Keusch, H. Gut, Danièle Salaün, Giovanni Mazzarol, Davide Disalvatore, Mohamed Bentires‐Alj, Pier Paolo Di Fiore, Ali Badache, Nancy E. Hynes - Science Signaling 2014 cited by 156

  8. Decreased NK-cell tumour immunosurveillance consequent to JAK inhibition enhances metastasis in breast cancer models

    Authors: Alessia Bottos, Dagmar Gotthardt, Jason Gill, Albana Gattelli, Anna Frei, Alexandar Tzankov, Veronika Sexl, Aleksandra Wodnar‐Filipowicz, Nancy E. Hynes - Nature Communications 2016 cited by 105

  9. The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

    Authors: Leah N. Klapper, Stefanie Glathe, Nora Vaisman, Nancy E. Hynes, Glenn C. Andrews, Michael Sela, Yosef Yarden - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 446

  10. The role of overexpressed HER2 in transformation

    Authors: Richard M. Neve, Heidi A. Lane, Nancy E. Hynes - Annals of Oncology 2001 cited by 173

  11. The Serine Protease Inhibitor Protease Nexin-1 Controls Mammary Cancer Metastasis through LRP-1–Mediated MMP-9 Expression

    Authors: Bérengère Fayard, Fabrizio Bianchi, Julien H. Dey, Eliza Moreno, Sabrina Djaffer, Nancy E. Hynes, Denis Monard - Cancer Research 2009 cited by 139

  12. NADPH oxidase-mediated redox signaling promotes oxidative stress resistance and longevity through memo-1 in C. elegans

    Authors: Collin Y. Ewald, John M Hourihan, Monet S. Bland, Carolin Obieglo, Iskra Katic, Lorenza E Moronetti Mazzeo, Joy Alcedo, T. Keith Blackwell, Nancy E. Hynes - eLife 2017 cited by 87

  13. The biology of erbB-2/nue/HER-2 and its role in cancer

    Authors: Nancy E. Hynes - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1994 cited by 972

  14. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.

    Authors: Ali Badache, Nancy E. Hynes - 2001 cited by 193

  15. ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.

    Authors: Devarajan Karunagaran, Eldad Tzahar, Roger R. Beerli, Xiomei Chen, Diana Graus-Porta, Barry Ratzkin, Rony Seger, Nancy E. Hynes, Yosef Yarden - The EMBO Journal 1996 cited by 674

  16. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets

    Authors: Simon Wöhrle, Christine Henninger, Olivier Bonny, Anne Thuery, Noémie Beluch, Nancy E. Hynes, Vito Guagnano, William R. Sellers, Francesco Hofmann, Michaela Kneissel, Diana Graus Porta - Journal of Bone and Mineral Research 2012 cited by 147

  17. Mammary Gland Growth Factors: Roles in Normal Development and in Cancer

    Authors: Nancy E. Hynes, Christopher J.E. Watson - Cold Spring Harbor Perspectives in Biology 2010 cited by 114

  18. Knowledge gaps in oncoplastic breast surgery

    Authors: William P. Weber, Monica Morrow, Jana de Boniface, Andrea L. Pusic, Giacomo Montagna, Elisabeth A. Kappos, Mathilde Ritter, Martin Haug, Christian Kurzeder, Ramon Saccilotto, Alexandra Schulz, John R. Benson, Florian Fitzal, Zoltán Mátrai, Jane Shaw, Marie‐Jeanne Vrancken Peeters, Shelley Potter, Joerg Heil, Eduardo González, Mona Elzayat, Rupert Koller, Michael Gnant, Fabrício Palermo Brenelli, Régis Resende Paulinelli, Vappu Zobel, Sarianna Joukainen, Ulla Karhunen‐Enckell, Susanna Kauhanen, Jean-Marc Piat, Vesna Bjelic‐Radisic, Andreé Faridi, Christoph Heitmann, Juergen Hoffmann, Ulrich Kneser, Sherko Kümmel, Thorsten Kühn, Michalis Kontos, Ekaterini Christina Tampaki, Mitchel Barry, Tanir M. Allweis, Moshe Carmon, Tal Hadar, Giuseppe Catanuto, Carlos A. Garcia‐Etienne, Oreste ­Gentilini, Susan Knox, Barbara C. Klein, Linetta B. Koppert, Pedro Gouveia, Tor Svensjö, Heiner C. Bucher, S.M. Ess, Ursula Ganz-Blättler, Andreas R. Günthert, Nik Hauser, Nancy E. Hynes, Michael Knauer, M Pfeiffer, Christoph Rochlitz, Christoph Tausch, Yves Harder, Frank Zimmermann, Fabienne D. Schwab, Veronica D’Amico, Savas D. Soysal, Liliana Castrezana López, Ilario Fulco, Lars G. Hemkens, Visnu Lohsiriwat, Bahadır M. Güllüoğlu, Güldeniz Karadeniz, Hasan Karanlık, Atakan Sezer, Mehmet Ali Gülçelik, Mustafa Emiroğlu, Tibor Kovács, Tim Rattay, Laszlo Romics, Raghavan Vidya, Lynda Wyld, Mahmoud El‐Tamer, Virgilio Sacchini - The Lancet Oncology 2020 cited by 62

  19. ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases

    Authors: Monilola A. Olayioye, Iwan Beuvink, K Horsch, J.M. Daly, Nancy E. Hynes - Journal of Biological Chemistry 1999 cited by 366

  20. Single-Chain Antibody-Mediated Intracellular Retention of ErbB-2 Impairs Neu Differentiation Factor and Epidermal Growth Factor Signaling

    Authors: Diana Graus-Porta, Roger R. Beerli, Nancy E. Hynes - Molecular and Cellular Biology 1995 cited by 298

  21. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation

    Authors: Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber, Nancy E. Hynes - Breast Cancer Research 2007 cited by 229

  22. FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone

    Authors: Simon Wöhrle, Olivier Bonny, Noémie Beluch, Swann Gaulis, Christelle Stamm, Marcel Scheibler, Mathias Müller, Bernd Kinzel, Anne Thuery, Joseph Brueggen, Nancy E. Hynes, William R. Sellers, Francesco Hofmann, Diana Graus-Porta - Journal of Bone and Mineral Research 2011 cited by 147

  23. The ErbB receptor tyrosine family as signal integrators.

    Authors: Nancy E. Hynes, K Horsch, Monilola A. Olayioye, Ali Badache - Endocrine Related Cancer 2001 cited by 140

  24. Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists.

    Authors: Ina Maria Harwerth, Winfried S. Wels, Barbara Marte, Nancy E. Hynes - Journal of Biological Chemistry 1992 cited by 122